| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
|
-
| | | Operating Expenses | | Research Development | 4,530 | 5,052 | 5,607 | 5,171 | | Selling General and Administrative | 2,417 | 2,592 | 3,096 | 3,121 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,947) | (7,644) | (8,703) | (8,292) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8 | 16 | 5 | 102 | | Earnings Before Interest And Taxes | (6,939) | (7,628) | (8,698) | (8,190) | | Interest Expense | 252 | 280 | 302 | 348 | | Income Before Tax | (7,191) | (7,908) | (9,000) | (8,538) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,191) | (7,908) | (9,000) | (8,538) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,191) | (7,908) | (9,000) | (8,538) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,191) | ($7,908) | ($9,000) | ($8,538) |
|
0.02% Nasdaq 
0.01 (1.52%) 
Income Statement
